FDA Approves Pfizer’s ABRYSVO Vaccine for the Prevention of RSV
Pfizer’s ABRYSVO, a respiratory syncytial virus (RSV) vaccine, has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age by active immunization of pregnant women at 32 through 36 weeks gestational age.
Mpox: Lessons Learned
The U.S. Monkeypox (mpox) public health emergency formally ended in early 2023. Yet, while mpox isn’t completely gone, the average number of daily cases has dwindled into the single digits. Still, many questions for public health officials remain.
Experimental mRNA Vaccine Plus Keytruda Delays Melanoma Recurrence
A new study shows that a personalized messenger RNA (mRNA) cancer vaccine plus the checkpoint inhibitor Keytruda (pembrolizumab) reduced the risk of recurrence or death in people with high-risk advanced melanoma.
Study Finds Experimental Alzheimer’s Drug Slows Cognitive Decline
A large clinical trial of Eli Lilly’s experimental Alzheimer’s medication, donanemab found the drug slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third.
Myths & Facts: Autism
Dispelling the myths surrounding this condition can help parents and caregivers support individuals with ASD, as well as clear up stereotypes and misunderstandings often associated with it.
A Primer on Mpox
Most human cases of this zoonotic virus are mild, but knowing the signs, symptoms and preventive measures for transmitting this disease remains important for public health.
Update on Toxoplasmosis
Because there is no cure or vaccine for this widespread parasitic infection, knowing how toxoplasmosis is spread and best practices for preventing transmission remains important.
Study Finds IVIG Effective for Treating Dermatomyositis
A study evaluating intravenous immune globulin for the treatment of dermatomyositis has found it significantly improved patient outcomes.
Regen BioPharma Files Patent for mRNA Cancer Vaccine
Regen BioPharma has filed a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented mRNA cancer immunotherapeutic vaccine.
First Malaria Vaccine Prequalified by WHO
The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.
